Penumbra (PEN) Cash & Equivalents (2014 - 2026)
Penumbra (PEN) posted quarterly Cash & Equivalents of $205.3 million for Q2 2026, down 51.33% year-over-year from $421.8 million in Q2 2025, and down 14.93% quarter-over-quarter from $241.3 million in Q1 2026.
Penumbra (PEN) Cash & Equivalents (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Cash & Equivalents for 13 consecutive years, with $205.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Equivalents fell 51.33% year-over-year to $205.3 million; the TTM figure through Jun 2026 stood at $205.3 million (down 51.33% YoY), while the FY2025 annual figure was $186.9 million, down 42.39% from the prior year.
- Cash & Equivalents eased to $205.3 million in Q2 2026 per PEN's latest filing, from $241.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $421.8 million in Q2 2025 and bottomed at $54.8 million in Q3 2022.
- Historically, Cash & Equivalents has averaged $199.8 million across 5 years, with a median of $196.1 million in 2025.
- Annual changes were most pronounced in 2024 — Cash & Equivalents soared 178.37% — and 2026, when it plunged 51.33%.
- Penumbra's Cash & Equivalents stood at $69.9 million in 2022, then jumped by 139.75% to $167.5 million in 2023, then soared by 93.69% to $324.4 million in 2024, then plunged by 42.39% to $186.9 million in 2025, then rose by 9.83% to $205.3 million in 2026.
- Business Quant data shows PEN's Cash & Equivalents at $205.3 million in Q2 2026, $241.3 million in Q1 2026, and $186.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 205.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.27 Mn |
| Mar 31, 2026 | 241.29 Mn |
| Dec 31, 2025 | 186.90 Mn |
| Sep 30, 2025 | 321.03 Mn |
| Jun 30, 2025 | 421.77 Mn |
| Mar 31, 2025 | 376.05 Mn |
| Dec 31, 2024 | 324.40 Mn |
| Sep 30, 2024 | 280.48 Mn |
| Jun 30, 2024 | 288.33 Mn |
| Mar 31, 2024 | 223.11 Mn |
| Dec 31, 2023 | 167.49 Mn |
| Sep 30, 2023 | 100.76 Mn |
| Jun 30, 2023 | 114.17 Mn |
| Mar 31, 2023 | 94.69 Mn |
| Dec 31, 2022 | 69.86 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 58.23 Mn |
| Mar 31, 2022 | 68.16 Mn |
| Dec 31, 2021 | 59.38 Mn |
| Sep 30, 2021 | 66.29 Mn |